FIELD: medicine.
SUBSTANCE: method involves carrying out bacteriological study of esophageal mucous membrane biopsy samples. No microorganism growth or predominant Streptococcus spp., Peptostreptococcus spp., Staphylococcus spp. in monoculture or culture association in the amount of equal to or greater than 103-104 CFU/g (colony formation units), and no Escherichia coli, Bacteroides spp., Enterococcus faecalis, Enterococcus faecium, Candida spp. in monoculture or culture association in the amount of equal to or greater than 102-107 CFU/g, and optionally increased total microorganisms quantity to 104-107 CFU/g being observed, alkaline ingredient availability in refluxate in gastroesophageal reflux cases is declared to take place.
EFFECT: enabled alkaline ingredient availability and microbiocenosis disorders intensity evaluation.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSTICS OF REFLUX TYPE WITH GASTROESOPHAGEAL REFLUX DISEASE | 2018 |
|
RU2671962C1 |
METHOD FOR EVALUATING MICROBIOCENOSIS DISORDER MANIFESTATIONS IN STOMACH STUMP AFTER ITS RESECTION | 2004 |
|
RU2279078C2 |
METHOD FOR PREDICTING PRENEOPLASTIC COMPLICATIONS OF GASTROESOPHAGEAL REFLUX DISEASE | 2003 |
|
RU2229712C2 |
METHOD FOR DIAGNOSING THE CASES OF GASTROESOPHAGEAL REFLUX | 2000 |
|
RU2191537C2 |
METHOD FOR PREDICTING ESOPHAGEAL MOTOR FUNCTION | 2003 |
|
RU2239358C1 |
METHOD OF DIAGNOSTICS OF THE BARRETT ESOPHAGUS IN PATIENTS WITH COMPLICATIONS FROM GASTROESOPHAGEAL REFLUX DISEASE | 2017 |
|
RU2655807C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF REFLUX-ESOPHAGITIS DEGREE | 2003 |
|
RU2257149C2 |
METHOD FOR ASSESSING ANTIREFLUX EFFECT OF DRINKING MINERAL WATER IN CASE OF GASTROESOPHAGEAL REFLUX DISEASE | 2022 |
|
RU2801416C1 |
METHOD FOR DETERMINATION OF SEVERITY LEVEL OF REFLUX GASTRITIS AMONG CHILDREN | 2007 |
|
RU2339313C1 |
METHOD OF TREATING PATIENTS WITH ULCERATIVE COLITIS | 2009 |
|
RU2419443C1 |
Authors
Dates
2007-11-20—Published
2005-09-16—Filed